A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2007
12/26/2007	CN100357321C Stimulative phagocytizing factor and coded gene and application
12/26/2007	CN100357317C Pegylated T20 polypeptide
12/26/2007	CN100357270C D-proline derivative
12/26/2007	CN100357267C Use of 2,4-diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors
12/26/2007	CN100356987C Thrombin-carrying bioabsorbable synthetic nonwoven fabric
12/26/2007	CN100356982C Adeno-associated virus vector preparation and medicinal composition containing it and its use
12/26/2007	CN100356978C Novel exendin agonist formulations and methods administration thereof
12/26/2007	CN100356977C Regenerated human blood-platelet derivative growth factor gel
12/26/2007	CN100356853C Antimicrobial agent
12/26/2007	CA2610439A1 Unit dosage forms of temozolomide
12/25/2007	US7312373 Nonhuman model animal lacking the ability to control lymphocyte migration
12/25/2007	US7312358 Dysmenorrhea; congestive heart failure; liver disorders; vision defects
12/25/2007	US7312333 N-heterocyclic hydroxyethylamine compounds; human immunodeficiency virus (HIV) protease
12/25/2007	US7312325 RNA aptamers and methods for identifying the same
12/25/2007	US7312321 Antibody to human enzymes of the metalloprotease family
12/25/2007	US7312319 Neurotrophic factor (NT-4) immunoassay systems
12/25/2007	US7312317 P2Y4 antibodies
12/25/2007	US7312314 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
12/25/2007	US7312313 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
12/25/2007	US7312312 PRO6242 polypeptides
12/25/2007	US7312311 Attaching substances to microorganisms
12/25/2007	US7312310 PRO6015 polypeptides
12/25/2007	US7312308 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
12/25/2007	US7312306 Wound healing agents; anticoagulants
12/25/2007	US7312305 Tumor cytotoxicity induced by modulators of the CXCR4 receptor
12/25/2007	US7312304 Somatostatin agonists
12/25/2007	US7312244 For therapy of cancer, as antitumor agent
12/25/2007	US7312237 Combination of epothilone analogs and chemotherapeutic agents for the treatment of prolilferative diseases
12/25/2007	US7312206 Sterol derivatives, liposomes comprising sterol derivatives and method for loading liposomes with active substances
12/25/2007	US7312198 Protein compositions for promoting wound healing and skin regeneration
12/25/2007	US7312197 Method of modifying glucose activity using polypeptides selectively expressed in fat tissue
12/25/2007	US7312196 Formulations for amylin agonist peptides
12/25/2007	US7312195 Pain, stroke, traumatic brain injury, blocking a voltage-sensitive calcium channel, blocking the nicotinic acetylcholine receptor; synthetic, has no free N- or C-terminus, cysteine residues bonded to form a disulfide bond
12/25/2007	US7312194 Delivery systems
12/25/2007	US7312193 Calcium phosphopeptide complexes
12/25/2007	US7312192 For treating diseases including diabetes
12/25/2007	US7312191 prenylation enzyme inhibitors such as 5,9,13-trimethyl-2-nitrotetradeca-2,8,12-triene, used as anticarcinogenic or antitumor agents
12/25/2007	US7312190 Pharmaceutical compositions of apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
12/25/2007	US7312189 Agent for treatment of inflammatory bowel disease
12/25/2007	US7312188 Alzheimer's disease; for promoting secretion of amyloid precursor protein-alpha (sAPP)
12/25/2007	US7312080 Plant resistance to insect pests mediated by viral proteins
12/25/2007	US7312078 Methods of controlling proliferation and differentiation of stem and progenitor cells
12/25/2007	US7312076 Genetic engineered polypeptide binds to a pathogen; mucosal surface-colonizing; vaginas; HIV; Herpes
12/25/2007	US7312051 Polynucleotides encoding dendritic enriched secreted lymphocyte activation molecule
12/25/2007	US7312050 Nucleic acids encoding interphotoreceptor matrix proteins
12/25/2007	US7312045 Metalloenzyme polypeptides for identifying modulators of protease cleavage; antiarthritic agents; antiinflammatory agents
12/25/2007	US7312044 Type 1 ryanodine receptor-based methods
12/25/2007	US7312041 Methods of diagnosing cervical cancer
12/25/2007	US7312038 Photocleavable bioreactive agents
12/25/2007	US7311920 Virus coat protein/receptor chimeras and methods of use
12/25/2007	US7311918 Generation of rotavirus subunit proteins for use in vaccines and methods of providing protective immunity to vertebrates, including humans, against rotavirus infection or disease; providing cell-mediated immune response
12/25/2007	US7311917 Membrane proteins; fusion proteins; vaccines; kits
12/25/2007	US7311916 targets particular molecules that occur at the cell surface of HIV during viral entry into host cells; humoral response generated in vivo as a prophylactic measure in individuals to reduce or inhibit the ability of HIV to infect uninfected cells; mechanism of HIV cell entry
12/25/2007	US7311912 immunoglobulin heavy chain peptides used for delivery of enzymes, antibodies, single chain antigen binding proteins, antigen combining sites, nucleic acids, carbohydrates and lipids to a basolateral factor of an epithelial surfaces; tissue-targeted therapy
12/25/2007	US7311911 Methods for inhibiting angiogenesis
12/25/2007	US7311910 Inhibiting interaction of CTLA4(Cytotoxic T-Lymphocyte Antigen 4)positive T cells with B7-1 or B7-2 positive cells by contacting with an antibody or antibody fragment which recognizes and binds an extracellular domain; tissue transplant rejection; graft versus host disease
12/25/2007	US7311909 PRO4348 antibodies
12/25/2007	US7311908 Pharmaceutical compositions of fibrinolytic agent
12/25/2007	US7311903 Recombinant cytokine for use in treatment of viral infection and cell proliferative disorders
12/25/2007	US7311902 Conjugates comprising human IL-18 and substitution mutants thereof
12/21/2007	WO2007147098A2 Identification and use of non-peptide analogs of rnaiii-inhibiting peptide for the treatment of staphylococcal infections
12/21/2007	WO2007147014A2 Method and systems for using biopolymer-based beads and hydrogels
12/21/2007	WO2007146897A2 The treatment of xerostomia
12/21/2007	WO2007146786A1 Pharmaceutical compositions and methods for restoring b-cell mass and function
12/21/2007	WO2007146747A2 Pas kinase regulates energy homeostasis
12/21/2007	WO2007146448A1 Pharmaceutical formulations of glp-1 derivatives
12/21/2007	WO2007146331A1 Tannate salt form of polypeptide mixtures, their preparation and use
12/21/2007	WO2007146319A2 Methods and apparatus for using polymer-based beads and hydrogels for cardiac applications
12/21/2007	WO2007146313A1 Compositions, methods and kits for enhancing weight loss while inhibiting loss of lean body mass
12/21/2007	WO2007146234A2 Solid oral dosage form containing an enhancer
12/21/2007	WO2007146232A2 Compositions and methods for repair of tissues
12/21/2007	WO2007146185A2 Uses of lectin-conotoxin
12/21/2007	WO2007146126A2 Insulin composition
12/21/2007	WO2007146104A2 Substrates and inhibitors of antiplasmin cleaving enzyme and methods of use
12/21/2007	WO2007146038A2 Albumin fusion proteins
12/21/2007	WO2007145987A1 J-superfamily conotoxin peptides
12/21/2007	WO2007145934A1 Combination of insulin and ascorbate to enhance wound healing
12/21/2007	WO2007145672A2 Combinations of human proteins to enhance viability of stem cells and progenitor cells
12/21/2007	WO2007145659A1 Synthetic ldl as targeted drug delivery vehicle
12/21/2007	WO2007145618A1 Topical treatment for diseases of eye surface
12/21/2007	WO2007145589A1 Peptides that are capable of binding to amyloid-beta peptide.
12/21/2007	WO2007145365A1 Therapeutic agent for cancer and method for screening for the same
12/21/2007	WO2007145318A1 Sparc-derived cancer rejection antigen peptide and pharmaceutical comprising the same
12/21/2007	WO2007145208A1 Peptide derivative
12/21/2007	WO2007144979A1 Peptide derivative
12/21/2007	WO2007144882A2 Targeted chimeric proteins
12/21/2007	WO2007144685A1 Cd4 mimic peptides and their uses
12/21/2007	WO2007144554A2 Gnrh (gonadotropin-releasing hormone) peptide variants
12/21/2007	WO2007144492A2 Peptides with anti-proliferative activity
12/21/2007	WO2007144475A1 Method for producing lipase, transformed yarrowia lipolytica cell capable of producing said lipase and their uses
12/21/2007	WO2007144397A1 Induction of tolerance to egg proteins
12/21/2007	WO2007144218A1 Use of thymosin alpha 1 for preparing a medicament for the treatment of stage iv malignant melanoma
12/21/2007	WO2007144198A2 Fplr-1 inhibitors for use in diseases involving amyloid-induced inflammatory events (flipr and flipr-like) and immunecomplex-mediated diseases
12/21/2007	WO2007144196A2 Peptide compounds for treating refractory status epilepticus
12/21/2007	WO2007144195A2 Pharmaceutical composition with synergistic anticonvulsant effect
12/21/2007	WO2007143934A1 Pharmaceutical composition for the prophylaxis and treatment of hiv infection and its use
12/21/2007	WO2007143858A1 Dph2 gene deletion mutant and uses thereof
12/21/2007	WO2007143794A1 Formulation comprising whey protein and hydrolysates for improving muscle recovery
12/21/2007	WO2007122213A3 Means and methods for diagnosing and treating cancer based on the frmd3 gene
12/21/2007	WO2007122187A3 Use of fungal polysaccharides as pharmaceutical composition or food complements

1 ... 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 ... 3163